ADVI Health的动态

Step into the Future: Discover How Digital Tools Are Redefining Medicine in GMDP Academy's Module 8. #medicinesdevelopment #pharma #cpd #futureofmedicine

Hello connection's ?? I am glad to share that I have completed certification course from THE GLOBAL HEALTH NETWORK on Topic - INTRODUCTION TO CLINICAL RESEARCH. #GLOBALHEALTHANDTRANINGCENTRE #THEGLOBALHEALTHNETWORK #ALERRT #REDe #Globalresearch #pharma #clinicaltrial #clinicalresearch

??? Are decentralized clinical trials the future of pharma? Imagine ?? ?????????? ?????????? ???????????????? ???????????? ???????????? ???????????????? ?? ?????????????? ??s, not just in specialized centers. Decentralized trials (DCTs) are making that possible—and they’re gaining serious momentum. In our latest carousel, we dive into: ?? What DCTs are really about ?? Why they’re rapidly growing ?? The career paths emerging from this shift Curious how this trend could redefine the industry—and your role in it? ?? Swipe through to find out! #headcountag #lifescience #pharma #clinicaltrials #digitalhealth

Personalized medicine, clinical chemistry, or even criminology: Diagnostics is becoming increasingly important in modern medicine. The biggest challenge? Expertise that goes far beyond filling and closing. High-tech solutions are needed. That’s why Optima specializes in the development of turnkey solutions and takes central responsibility with multiple systems from one source. “Our diagnostic customers benefit from the experience and expertise we have gained over many years of providing turnkey solutions to the pharmaceutical industry. This ensures a strong and well-established technical foundation for such tasks," says Christian Müller, Director Sales Diagnostic Global at Optima Pharma. Read the whole expert interview in the latest issue of o-com diagnostic, Page 8 - 13 ?? https://lnkd.in/eRWNDUDC #optima #wecareforpeople #pharma #diagnostic #medicine #turnkey

Clinical trials are at the core of innovation in medicine. They are the link between pharma and patients, which aligns with our mission at COREX. This is why Clinical Trial Supply is so important to us. Our goal is always to ensure that a trial runs smoothly to make sure that the outcome will be life-changing therapies for patients everywhere. From drugs to reagents and samples, to equipment for labs, warehouses and manufacturers, no request is too big or too small. And at the heart of it all, we care about patients. Learn more about our Clinical Trial Supply services here????https://lnkd.in/dhHygUem #clinicaltrials #healthcareinnovation #clinicaltrialsupply #coldchainlogistics

Pharma companies are using lab data to reach patients faster and more effectively. https://ow.ly/6VBc50Um84h. Dr. Madeline Naylor, DHSc, MSc, ACRP-CP, Vice President of Health Informatics, RWD at Norstella, writes about how lab data is being used across the product lifecycle, from drug development to patient monitoring. Learn how NorstellaLinQ fills in the gaps associated with typical real-world data assets, enabling a 360-degree view of the patient journey. #Pipeline2Patient #FollowNorstella #Pharma #LabData #PatientJourney #ClinicalResearch

The evolution of new technologies has transformed how journal performance is evaluated ???? ?? https://ow.ly/PFyc50ThcLb This transformation provides a great opportunity for publication teams within medical affairs and pharma to shift away from conventional citation-based metrics. Instead, they can delve into alternative impact metrics that better reflect the various facets of contemporary research dissemination and engagement. ?? Explore the effective utilization of the newest impact metrics for journal selection by checking out our recently launched whitepaper ?? https://ow.ly/PFyc50ThcLb #MedAffairs #Pharma #PharmaResearch #PharmaJournals #ImpactMetrics #JournalSelection

Come hear from our panel for a discussion on how changing healthcare policies, evolving market dynamics, and advancements in technology and scientific research increase the complexity that companies in the pharmaceuticals and life sciences industry face. Eligible for CPE/CLE credit. https://pwc.to/4dtowDo

The latest article in PharmaVoice’s Crystal Ball series looks at how innovations and new challenges in the #pharma industry will impact clinical development, policy and access in the year ahead. This list of predictions on what 2025 may bring includes Joe DePinto’s insights on the expansion of new #CellandGeneTherapies. https://lnkd.in/et5482xq #2025Predictions #CGT